Design of Salbutamol Sulphate Gastroretentive Nanoparticles via Surface Charge Manipulation

Authors: Diky Mudhakir, M. Fauzi Bostanudin, Fiki Firmawan, Rachmat Mauludin

Abstract:

In the present study, development of salbutamol sulphate nanoparticles that adhere to gastric mucus was investigated. Salbutamol sulphate has low bioavailability due to short transit time in gastric. It also has a positive surface charge that provides hurdles to be encapsulated by the positively strong mucoadhesive polymer of chitosan. To overcome the difficulties, the surface charge of active ingredient was modified using several nonionic and anionic stomach-specific polymers. The nanoparticles were prepared using ionotropic gelation technique. The evaluation involved determination of particle size, zeta potential, entrapment efficiency, in vitro drug release and in vitro mucoadhesion test. Results exhibited that the use of anionic alginate polymer was more satisfactory than that of nonionic polymer. Characteristics of the particles was nano-size, high encapsulation efficiency, fulfilled the drug release requirements and adhesive towards stomach for around 11 hours. This result shows that the salbutamol sulphate nanoparticles can be utilized for improvement its delivery.

Keywords: Mucoadhesive, salbutamol sulphate, nanosize, anionic polymer.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1072307

References:

[1] S.K. Lai, Y. Wang, and J. Hanes, "Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues", Adv. Drug Deliv. Rev., vol. 61, no. 2, 2009, pp. 158-171.
[2] K. Sailaja, P. Amareshwar, and P. Chakravarty, "Chitosan nanoparticles as a drug delivery systems", Res. J. Pharm. Biol. Chem. Sci., vol. 1, no. 3, 2010, pp. 474-484.
[3] W.H. Huang, Z.J. Yang, H. Wu, Y.F. Wong, Z.Z. Zhao, and L. Liu," Development of liposomal salbutamol sulphate dry powder inhaler formulation", Biol. Pharm. Bull., vol. 33, no. 3, 2010, p. 527-517.
[4] E.S. El-Leithy, D.S. Shaker, M.K. Ghorab, and R.S. Abdel-Rashid, "Evaluation of mucoadhesive hydrogels loaded with diclofenac sodium-chitosan microspheres for rectal administration", AAPS Pharm. Sci. Tech., vol. 11, no. 4, 2010, pp. 1695-1702.
[5] B. Patel, P. Patel, A. Bhosale, S. Hardikar, S. Mutha, and G. Chaulang, "Evaluation of tamarind seed polysaccharide (TSP) as a mucoadhesive and sustained release component of nifedipine buccoadhesive tablet & comparison with HPMC and CMC Na", Int. J. Pharm. Tech. Res., vol. 1, no. 3, 2009, pp. 404-410.
[6] C.R. Palem, R. Gannu, N. Doodipala, V.V. Yamsani, and M.R. Yamsani, "Transmucosal delivery of domperidone from bilayered buccal patches: in vitro, ex vivo and in vivo characterization", Arch. Pharm. Res., vol. 34, no. 10, 2011, pp. 1701-1710.
[7] L. Bromberg, M. Temchenko, V. Alakhov, T.A. Hatton, "Bioadhesive properties and rheology of polyether-modified poly(acrylic acid) hydrogels", Int. J. Pharm., vol. 282, no. 1-2, 2004, pp. 45-60.
[8] S. Dhawan, V.R. Sinha, A.K. Singla, S. Wardhawan, R. Kaushik, R. Kumria, and K. Bansal, "Chitosan microsphere as a potential carrier for drugs", Int. J. Pharm., vol.274, 2004, pp. 1-33.
[9] P. Calvo, C. Remunan-Lopez, J.L. Vila-Jato, and M.J. Alonso, "Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers", J. App. Pol. Sci, vol. 63, 1997, pp. 125-132.
[10] A. Nasti, N.M. Zaki, P. Leonardis, S. Ungphaiboon, P. Sansongsak, M.G. Rimoli, and N. Tirelli, "Chitosan/TPP and Chitosan/TPP-hyaluronic acid nanoparticles: systemic optimization of preparative process and preliminary biological evaluation", Pharm. Res., vol. 26, no. 8, 2009, pp. 1918-1930.
[11] M.P. Deacon, S. McGurk, C.J. Roberts, P.M. William, S.J. Tendler, M.C. Davies, S.S. Davis, and S.E. Harding,"Atomic force microscopy of gastric mucin and chitosan mucoadhesive systems", Biochem. J., vol. 348, no. 3, 2000, pp. 557-563.
[12] T. Gazori, M.R. Khoshayand, E. Azizi, P. Yazdizade, A. Nomani, and I. Haririan, "Evaluation of alginate/chitosan nanoparticles as antisense delivery vector: formulation, optimization and in vitro characterization", Carbohydrate Pol., vol 77, 2009, pp. 599-606.
[13] F.A. Oyarzun-Ampuero, J. Brea, M.I. Loza, D. Torres, and M.J. Alonso, "Chitosan-hyaluronic acid nanoparticles loaded with heparin for treatment of asthma", Int. J. Pharm., vol 381, 2009, pp. 122-129.
[14] S.B. Kiran, R.S. Dhumal, B. Chauhan, A. Paradkar, and S.S. Kadam, "Effect of oppositely charged polymer and dissolution medium on swelling, erosion, and drug release from chitosan matrices", AAPS Pharm. Sci. Tech., vol. 8, no. 2, 2007, article 44.
[15] S.T. Lim, G.P. Martin, D.J. Berry, and M.B. Brown, "Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan", J. Control Rel., vol. 66, 2000, pp. 281-292.
[16] E. Rytting, M. Bur, R. Cartier, T. Bouyssou, X. Wang, M. Kruger, C. Lehr, and T. Kissel, "In vitro and in vivo performance of biocompatible negatively-charged salbutamol-loaded nanoparticles, J. Control Rel., vol. 141, 2010, pp. 101-107.
[17] U.V. Bannakar, Pharmaceutical Dissolution Testing, Marcell Dekker, Inc., USA, 1992, pp. 322.